Metoclopramide Orifarm (Metoclopramide Hydrochloride)

The drug works by blocking dopamine D2 receptors in the chemoreceptor trigger zone of the brain, which diminishes the vomiting reflex. In the gastrointestinal tract it also blocks presynaptic dopamine receptors, leading to increased acetylcholine release and enhanced coordinated smooth‑muscle contractions that promote gastric motility.

The appropriate dose of Metoclopramide Orifarm is determined by the prescribing clinician based on the specific indication, patient age, renal function and other clinical factors. Patients should follow the exact dosing instructions provided by their healthcare professional and the product labeling.

The pregnancy safety category for Metoclopramide is listed as unknown, and data are limited. It should only be used during pregnancy or lactation when the potential benefit justifies any potential risk to the fetus or infant, and after a careful risk‑benefit assessment by the prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Metoclopramide differs from many anti‑emetics such as 5‑HT3 antagonists (e.g., ondansetron) by primarily targeting dopamine receptors and providing a pro‑kinetic effect that enhances gastric emptying. This dual action makes it useful for conditions where delayed gastric motility contributes to symptoms, whereas other agents may lack this gastrointestinal benefit.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging is tightly closed to maintain product stability throughout its shelf life.

Metoclopramide Orifarm is taken orally, usually with a glass of water. It may be administered with or without food, but consistent timing relative to meals can help maintain steady drug levels. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious adverse effects include extrapyramidal reactions such as dystonia or akathisia, tardive dyskinesia with prolonged use, and neuroleptic malignant syndrome. These events, although rare, require immediate medical attention and may necessitate discontinuation of therapy.

Metoclopramide is contraindicated in patients with known hypersensitivity to the drug, in those with a history of pheochromocytoma, and in individuals who have experienced severe extrapyramidal reactions to dopamine antagonists. Caution is also advised for patients with gastrointestinal obstruction, perforation, or hemorrhage.